Procarta receives CARB-X Award of up to $9.2 Million
For the development of new class of antibiotics to combat life-threatening drug-resistant pathogens
The NHS leads the way with world’s first drug ‘subscription’ scheme to tackle global antimicrobial resistance crisis
Atelerix Consortium Awarded £267,000
Innovate UK Grant for collaboration with the Cell and Gene Therapy Catapult and Rexgenero on Cell Therapy Stabilisation Technologies
Sharing the Secrets of Start-up Success
Supporting start-ups to maximise success for both the company and the industry
SynbiCITE’s 4-day MBA: Advancing the next generation of synthetic biology companies
More Than Just Money
UKI2S' experienced team works with scientists and entrepreneurs from the earliest stages to build great companies using patient capital.
Please click on the maps below to launch google maps from where you will be able to search for our directions to our offices
